News
Bioiberica has created a New Technologies Division with the aim of addressing the needs of all patients suffering from chondral pathologies, while taking a further step away from conventional therapy towards more specific, personalized and effective treatments for every patient.
With the aim of promoting scientific research at the rheumatology units of Spanish hospitals and the continuous training of rheumatologists, the Spanish Rheumatology Society (SER), in conjunction with Bioiberica, provides grants to allow researchers to attend the OARSI World Congress on Osteoarthritis.
Bioiberica is a company with over 30 years of experience in the field of joint health and provides solutions to joint problems such as osteoarthritis, discomfort prior to the development of a disease, movement problems, and joint wear in sportspeople.
As an expansion of its existing ingredient business lines and with the aim of offering made-to-measure solutions for different kinds of patients and joint problems, Bioiberica Joint Care has completed its line of finished products with Tendoactive (specifically designed for tendon improvement and recuperation), Hyal-Joint Caps (for improving joint mobility) and Hyal-Rub (a topical product to ma
Bioiberica closed 2008 by participating in the three most important international conferences on diseases of the musculoskeletal system: those organized by EULAR, OARSI and ACR.